PPH ETF Forecast & Price Targets
PPH Analyst Ratings
Moderate Buy
23Buy2Hold0Sell
Based on the Wall Street analyst consensus for 25 of PPH’s holdings.
PPH 12 Month Forecast
Average Price Target
$136.28▲(14.20% Upside)Based on Wall Street analyst 12-month price targets for 25 of VanEck Pharmaceutical ETF’s holdings in the last 3 months. The average price target is $136.28 with a high forecast of $153.39 and a low forecast of $106.65. The average price target represents a 14.20% change from the last price of $119.33.
Past 12 Months12 Month ForecastJan2026Oct2026
High$153.39
Average$136.28
Low$106.65
Highest Price TargetHighest$153.39Average Price Target$136.28Lowest Price TargetLowest$106.65
PPH Stocks With Highest Upside Potential
PPH Stocks With Highest Downside Potential
PPH ETF FAQ
What is PPH’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 25 of PPH’s holdings, VanEck Pharmaceutical ETF’s 12-month average price target is $136.28.
What is PPH’s upside potential, based on the analysts’ average price target?
PPH’s average price target of $136.28 represents a 14.20% upside from its last price of $119.33.
Is PPH a Buy, Sell or Hold?
VanEck Pharmaceutical ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 25 of PPH’s holdings: 23 rated Buy, 2 rated Hold and 0 rated Sell.
What is VanEck Pharmaceutical ETF’s price target?
The average price target for VanEck Pharmaceutical ETF is $136.28, based on Wall Street analyst 12-month price targets for 25 of PPH’s holdings, issued in the past 3 months. The highest price target is $153.39 and the lowest is $106.65. The average price target represents a 14.20% increase from the last price of $119.33.
What is PPH’s expense ratio?
PPH’s expense ratio is 0.36%.
How many holdings does PPH have?
PPH holds 26 assets.
How can I buy shares of PPH?
You can buy shares of PPH through a brokerage account. Compare brokers on our Best Online Brokers page.
